- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/07 - Tetrapeptides
Patent holdings for IPC class A61K 38/07
Total number of patents in this class: 1757
10-year publication summary
124
|
154
|
149
|
175
|
135
|
187
|
148
|
126
|
128
|
67
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Stealth Biotherapeutics Inc. | 170 |
74 |
CARA Therapeutics, Inc. | 65 |
36 |
The Regents of the University of California | 19898 |
21 |
Cornell Research Foundation, Inc. | 265 |
19 |
Amgen Inc. | 4072 |
18 |
Cornell University | 3302 |
17 |
Onyx Therapeutics, Inc. | 68 |
17 |
ISP Investments Inc. | 464 |
15 |
Biotempt B.V. | 30 |
14 |
Mondobiotech Laboratories AG | 311 |
14 |
S.i.s. Shulov Innovative Science Ltd. | 15 |
14 |
Stealth Biotherapeutics Corp | 36 |
14 |
Stealth Peptides International, Inc. | 31 |
14 |
Agency for Science, Technology and Research | 3616 |
13 |
Northwestern University | 3386 |
13 |
The Feinstein Institute for Medical Research | 254 |
13 |
SeaGen Inc | 587 |
13 |
Cytogel Pharma, LLC | 23 |
12 |
Centre National de La Recherche Scientifique | 10421 |
11 |
Purdue Research Foundation | 3601 |
10 |
Other owners | 1385 |